Back to top

Analyst Blog

Abbott Laboratories (ABT - Analyst Report) recently announced that the company obtained license for its RealTime High Risk HPV molecular diagnostic test from the Medical Device Bureau of Health Canada.

Abbott Labs’ RealTime High Risk HPV molecular diagnostic test enables detection of human papillomavirus (HPV) which is the prime cause of cervical cancer.

The test is performed on the Abbott Labs’ m2000 RealTime molecular diagnostics system and is already available in the US and Europe. 

We note that Abbott Labs continues to invest in the development of next-generation instruments and other advanced technologies in its diagnostics business.

Molecular diagnostics continues to be a key area of focus and Abbott Labs expects accelerated growth from molecular diagnostics in the second quarter of 2013 along with increased revenues from core laboratory and point of care diagnostics business. 

In Apr 2013, Abbott Labs launched a laboratory automation track system ACCELERATOR a3600, which is a next-generation track system to increase efficiency in laboratories.

Meanwhile, the nutrition business also holds promise and Abbott Labs expects accelerated growth from both the nutrition and diagnostics businesses in 2013.

We remind investors that Abbott Labs became a diversified medical products company focusing on branded generic pharmaceutical, medical devices, diagnostic and nutritional businesses following the separation of its research-based pharmaceuticals business into a new company, AbbVie Inc. (ABBV - Analyst Report), in Jan 2013.

We believe the diversification bodes well for Abbott Labs and should enable the company to counter the challenging business environment as a result of austerity measures undertaken by developed markets in 2013 coupled with weak economic conditions and a mixed global economy.

Abbott Labs currently carries a Zacks Rank #3 (Hold).  Right now, AtriCure, Inc. (ATRC - Snapshot Report) and TranS1 Inc look well placed with a Zacks Rank #2 (Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
RPC INC RES 24.91 +8.35%
LITHIA MOTO… LAD 94.59 +4.60%
DELTA AIR L… DAL 39.15 +3.90%
FLAMEL TECH… FLML 14.51 +3.50%
SOUTHWEST A… LUV 28.87 +2.92%